SeaStar Medical Holding Corporation
ICU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $183 | $338 | $293 | $67 |
| % Growth | -45.9% | 15.4% | 337.3% | – |
| Cost of Goods Sold | $14 | $27 | $0 | $0 |
| Gross Profit | $169 | $311 | $293 | $67 |
| % Margin | 92.3% | 92% | 100% | 100% |
| R&D Expenses | $1,850 | $1,037 | $2,431 | $2,738 |
| G&A Expenses | $1,898 | $1,030 | $1,684 | $2,096 |
| SG&A Expenses | $1,898 | $1,030 | $1,684 | $2,096 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,748 | $2,067 | $4,115 | $4,834 |
| Operating Income | -$3,579 | -$1,756 | -$3,822 | -$4,767 |
| % Margin | -1,955.7% | -519.5% | -1,304.4% | -7,114.9% |
| Other Income/Exp. Net | $107 | -$246 | $53 | $348 |
| Pre-Tax Income | -$3,472 | -$2,002 | -$3,769 | -$4,419 |
| Tax Expense | $0 | $0 | $3 | $0 |
| Net Income | -$3,472 | -$2,002 | -$3,772 | -$4,419 |
| % Margin | -1,897.3% | -592.3% | -1,287.4% | -6,595.5% |
| EPS | -0.13 | -0.11 | -0.44 | -0.9 |
| % Growth | -18.2% | 75% | 51.1% | – |
| EPS Diluted | -0.13 | -0.11 | -0.44 | -0.9 |
| Weighted Avg Shares Out | 26,393 | 17,506 | 8,618 | 4,920 |
| Weighted Avg Shares Out Dil | 26,393 | 17,506 | 8,618 | 4,920 |
| Supplemental Information | – | – | – | – |
| Interest Income | $107 | $45 | $48 | $19 |
| Interest Expense | $0 | $307 | $11 | -$253 |
| Depreciation & Amortization | $7 | $0 | $0 | -$253 |
| EBITDA | -$3,465 | -$1,993 | -$3,758 | -$4,672 |
| % Margin | -1,893.4% | -589.6% | -1,282.6% | -6,973.1% |